DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Windlas Biotech Limited — Board Meeting Intimation

NSE 1 hr ago·4 Aug 2026, 11:13 am

Windlas Biotech

Windlas Biotech has announced that its board of directors will meet on August 10, 2026, to review and approve the company's unaudited financial results for the quarter ending June 2026.

This scheduled meeting is a routine corporate action that signals the upcoming release of quarterly performance data. For investors, this is a key event as it provides a fresh look at the company's operational health and financial trajectory.

Investors should watch for the specific numbers released during the board meeting, particularly revenue growth and profit margins, to assess the company's current performance against market expectations.